Genetic Sensorineural Hearing Loss Differential Diagnoses

1. Centers for Disease Control and Prevention. Hearing Loss in Children. CDC. Available at https://www.cdc.gov/ncbddd/hearingloss/data.html. Reviewed: June 10, 2021; Accessed: June 30, 2022.

2. Usami SI, Nishio SY, Nagano M, Abe S, Yamaguchi T. Simultaneous Screening of Multiple Mutations by Invader Assay Improves Molecular Diagnosis of Hereditary Hearing Loss: A Multicenter Study. PLoS One. 2012. 7(2):e31276. [QxMD MEDLINE Link]. [Full Text].

3. Eisen MD, Ryugo DK. Hearing molecules: contributions from genetic deafness. Cell Mol Life Sci. 2007 Mar. 64(5):566-80. [QxMD MEDLINE Link]. [Full Text].

4. Vrijens K, Van Laer L, Van Camp G. Human hereditary hearing impairment: mouse models can help to solve the puzzle. Hum Genet. 2008 Nov. 124(4):325-48. [QxMD MEDLINE Link].

5. Van Camp G, SmithR. Cloned genes for nonsyndromic hearing impairment. Hereditary Hearing Loss Homepage. Available at http://hereditaryhearingloss.org/. Accessed: 04/14/09.

6. Brini M, Di Leva F, Domi T, Fedrizzi L, Lim D, Carafoli E. Plasma-membrane calcium pumps and hereditary deafness. Biochem Soc Trans. Nov 2007. 35 (pt 5):913-8.

7. Xing G, Chen Z, Cao X. Mitochondrial rRNA and tRNA and hearing function. Cell Res. 2007 Mar. 17(3):227-39. [QxMD MEDLINE Link]. [Full Text].

8. El-Amraoui A, Petit C. Usher I syndrome: unravelling the mechanisms that underlie the cohesion of the growing hair bundle in inner ear sensory cells. J Cell Sci. 2005 Oct 15. 118:4593-603. [QxMD MEDLINE Link].

9. National Institute on Deafness and Other Communication Disorders. Quick Statistics About Hearing. NIDCD. Available at https://www.nidcd.nih.gov/health/statistics/quick-statistics-hearing. Updated March 25, 2021; Accessed: June 30, 2022.

10. National Institute on Deafness and Other Communication Disorders. Age-Related Hearing Loss. NIDCD. Available at https://www.nidcd.nih.gov/health/age-related-hearing-loss. Updated March 16, 2022; Accessed: June 30, 2022.

11. World Health Organization. Deafness and hearing loss. WHO. Available at https://www.who.int/health-topics/hearing-loss. Accessed: June 30, 2022.

12. Saunders JE, Vaz S, Greinwald JH, Lai J, Morin L, Mojica K. Prevalence and etiology of hearing loss in rural Nicaraguan children. Laryngoscope. 2007 Mar. 117(3):387-98. [QxMD MEDLINE Link].

13. Angeli SI. Phenotype/genotype correlations in a DFNB1 cohort with ethnical diversity. Laryngoscope. 2008 Nov. 118(11):2014-23. [QxMD MEDLINE Link].

14. Schimmenti LA, Martinez A, Telatar M, et al. Infant hearing loss and connexin testing in a diverse population. Genet Med. 2008 Jul. 10(7):517-24. [QxMD MEDLINE Link].

15. Korres S, Nikolopoulos TP, Komkotou V, et al. Newborn hearing screening: effectiveness, importance of high-risk factors, and characteristics of infants in the neonatal intensive care unit and well-baby nursery. Otol Neurotol. 2005 Nov. 26(6):1186-90. [QxMD MEDLINE Link].

16. National Conference of State Legislatures. Newborn Hearing Screening State Laws. NCSL. Available at https://www.ncsl.org/research/health/newborn-hearing-screening-state-laws.aspx. August 5, 2021; Accessed: June 30, 2022.

17. Northern JL, Downs MP. Hearing in Children. 4th ed. Baltimore, Md: Williams & Wilkins; 1991. 28-31.

18. Mehta D, Noon SE, Schwartz E, et al. Outcomes of evaluation and testing of 660 individuals with hearing loss in a pediatric genetics of hearing loss clinic. Am J Med Genet A. 2016 Oct. 170 (10):2523-30. [QxMD MEDLINE Link].

19. Gigante M, d'Altilia M, Montemurno E, Diella S, Bruno F, Netti GS, et al. Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation. BMC Nephrol. 2013 Mar 18. 14:60. [QxMD MEDLINE Link]. [Full Text].

20. North HJD, Lloyd SKW. Hearing Rehabilitation in Neurofibromatosis Type 2. Adv Otorhinolaryngol. 2018. 81:93-104. [QxMD MEDLINE Link].

21. Chung LK, Nguyen TP, Sheppard JP, et al. A Systematic Review of Radiosurgery Versus Surgery for Neurofibromatosis Type 2 Vestibular Schwannomas. World Neurosurg. 2018 Jan. 109:47-58. [QxMD MEDLINE Link].

22. Koenekoop RK, Arriaga MA, Trzupek KM, et al. Usher Syndrome Type I. Updated 2020 Jun 25. [QxMD MEDLINE Link]. [Full Text].

23. Liu XZ, Angeli SI, Rajput K, et al. Cochlear implantation in individuals with Usher type 1 syndrome. Int J Pediatr Otorhinolaryngol. 2008 Jun. 72(6):841-7. [QxMD MEDLINE Link].

24. Besnard T, García-García G, Baux D, et al. Experience of targeted Usher exome sequencing as a clinical test. Mol Genet Genomic Med. 2014 Jan. 2(1):30-43. [QxMD MEDLINE Link]. [Full Text].

25. Yoshimura H, Iwasaki S, Nishio SY, et al. Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. PLoS One. 2014. 9(3):e90688. [QxMD MEDLINE Link]. [Full Text].

26. Shu HR, Bi H, Pan YC, Xu HY, Song JX, Hu J. Targeted exome sequencing reveals novel USH2A mutations in Chinese patients with simplex Usher syndrome. BMC Med Genet. 2015 Sep 16. 16:83. [QxMD MEDLINE Link]. [Full Text].

27. Soh LM, Druce M, Grossman AB, et al. Evaluation of genotype-phenotype relationships in patients referred for endocrine assessment in suspected Pendred syndrome. Eur J Endocrinol. 2015 Feb. 172 (2):217-26. [QxMD MEDLINE Link]. [Full Text].

28. Watson S, Padala SA, Bush JS. Alport Syndrome. StatPearls. 2020 Jan. [QxMD MEDLINE Link]. [Full Text].

29. Van Laer L, Cryns K, Smith RJ, Van Camp G. Nonsyndromic hearing loss. Ear Hear. 2003 Aug. 24(4):275-88. [QxMD MEDLINE Link].

30. Topsakal V, Hilgert N, van Dinther J, Tranebjaerg L, Rendtorff ND, Zarowski A, et al. Genotype-phenotype correlation for DFNA22: characterization of non-syndromic, autosomal dominant, progressive sensorineural hearing loss due to MYO6 mutations. Audiol Neurootol. 2010. 15(4):211-20. [QxMD MEDLINE Link].

31. Karamert R, Bayazit YA, Altinyay S, Yilmaz A, Menevse A, Gokdogan O, et al. Association of GJB2 gene mutation with cochlear implant performance in genetic non-syndromic hearing loss. Int J Pediatr Otorhinolaryngol. 2011 Dec. 75(12):1572-5. [QxMD MEDLINE Link].

32. Nadol JB Jr, Merchant SN. Histopathology and molecular genetics of hearing loss in the human. Int J Pediatr Otorhinolaryngol. 2001 Oct 19. 61(1):1-15. [QxMD MEDLINE Link].

33. Alzhrani F, Alhussini R, Hudeib R, Alkaff T, Islam T, Alsanosi A. The outcome of cochlear implantation among children with genetic syndromes. Eur Arch Otorhinolaryngol. 2018 Feb. 275 (2):365-9. [QxMD MEDLINE Link].

34. Arnos Kathleen. Ethical and social implications of genetic testing for communication disorders. Journal of Communication Disorders. September-October 2008. 41:444-457.

35. Mey K, Percy-Smith L, Hallstrom M, Sandvej M, Caye-Thomasen P. Receptive language acquisition in a pediatric population with Pendred syndrome and non-syndromic enlarged vestibular aqueduct. Acta Otolaryngol. 2020 Jan. 140 (1):46-50. [QxMD MEDLINE Link].

Stephanie A Moody Antonio, MD Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School

Stephanie A Moody Antonio, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, Virginia Society of Otolaryngology-Head and Neck Surgery, American Neurotology Society, American Medical Association

Disclosure: Nothing to disclose.

Barry Strasnick, MD, FACS Chairman, Professor, Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School

Barry Strasnick, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American College of Surgeons, American Medical Association, American Tinnitus Association, Ear Foundation Alumni Society, Norfolk Academy of Medicine, North American Skull Base Society, Society of University Otolaryngologists-Head and Neck Surgeons, Vestibular Disorders Association, Virginia Society of Otolaryngology-Head and Neck Surgery

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Ted L Tewfik, MD Professor of Otolaryngology-Head and Neck Surgery, Professor of Pediatric Surgery, McGill University Faculty of Medicine; Senior Staff, Montreal Children's Hospital, Montreal General Hospital, and Royal Victoria Hospital

Ted L Tewfik, MD is a member of the following medical societies: American Society of Pediatric Otolaryngology, Canadian Society of Otolaryngology-Head & Neck Surgery

Disclosure: Nothing to disclose.

Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan; Ryte; Neosoma; MI10<br/>Received income in an amount equal to or greater than $250 from: Neosoma; Cyberionix (CYBX)<br/>Received ownership interest from Cerescan for consulting for: Neosoma, MI10.

Robert A Battista, MD, FACS Assistant Professor of Otolaryngology, Northwestern University, The Feinberg School of Medicine; Physician, Ear Institute of Chicago, LLC

Robert A Battista, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, Illinois State Medical Society, American Neurotology Society, American College of Surgeons

Disclosure: Nothing to disclose.

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Karen K Hoffmann, MD, to the development and writing of this article.

• Print this section
• Print the entire contents of
• Print the entire contents of article